(Q50767432)

18 March 2018

title

TOP2A and HER-2 gene amplification in fine needle aspirates from breast carcinomas. (English)

1 reference

18 March 2018

author name string

Bofin AM

series ordinal

1

1 reference

18 March 2018

Ytterhus B

series ordinal

2

1 reference

18 March 2018

Hagmar BM

series ordinal

3

1 reference

18 March 2018

publication date

1 December 2003

1 reference

18 March 2018

published in

Cytopathology

1 reference

18 March 2018

volume

14

1 reference

18 March 2018

issue

6

1 reference

18 March 2018

page(s)

314-319

1 reference

18 March 2018

DNA topoisomerases: structure, function, and mechanism

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00088.X

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00088.X

Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00088.X

Amplification of HSD17B1 and ERBB2 in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00088.X

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00088.X

Abnormal chromosome 8 copy number in cytological smears from breast carcinomas detected by means of fluorescence in situ hybridization (FISH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00088.X

Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00088.X

Effects of HER-2/neu on chemosensitivity of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00088.X

Four regions of allelic imbalance on 17q12-qter associated with high-grade breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00088.X

Marked intratumoral heterogeneity of c-myc and cyclinD1 but not of c-erbB2 amplification in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00088.X

Topoisomerase II-alpha (topoII) and HER2 amplification in breast cancers and response to preoperative doxorubicin chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00088.X

Cytological grading of breast cancer in Giemsa-stained fine needle aspiration smears

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00088.X

Comparison of Topoisomerase-IIα Gene Status between Primary Breast Cancer and Corresponding Distant Metastatic Sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00088.X

Modification of topoisomerase genes copy number in newly diagnosed childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00088.X

10.1046/J.0956-5507.2003.00088.X

21 January 2018

Identifiers

DOI

1 reference

18 March 2018

1 reference

18 March 2018